Should I buy or sell Cognyte Software stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognyte Software in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CGNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNT, but not buy additional shares or sell existing shares. View CGNT analyst ratings or view top-rated stocks .

What is Cognyte Software's stock price target for 2024?

3 Wall Street research analysts have issued 1-year target prices for Cognyte Software's stock. Their CGNT share price targets range from $7.50 to $8.00. On average, they expect the company's stock price to reach $7.75 in the next year. This suggests a possible upside of 20.7% from the stock's current price. View analysts price targets for CGNT or view top-rated stocks among Wall Street analysts .

How have CGNT shares performed in 2024?

Cognyte Software's stock was trading at $6.43 on January 1st, 2024. Since then, CGNT stock has decreased by 0.2% and is now trading at $6.42. View the best growth stocks for 2024 here .

Are investors shorting Cognyte Software?

Cognyte Software saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 329,100 shares, a drop of 24.4% from the March 15th total of 435,200 shares. Based on an average daily volume of 457,300 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.5% of the shares of the company are sold short. View Cognyte Software's Short Interest .

When is Cognyte Software's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024. View our CGNT earnings forecast .

How were Cognyte Software's earnings last quarter?

Cognyte Software Ltd. (NASDAQ:CGNT) announced its quarterly earnings data on Thursday, June, 15th. The medical device company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.01. The medical device company had revenue of $73.40 million for the quarter, compared to analyst estimates of $71.53 million. Cognyte Software had a negative net margin of 4.97% and a negative trailing twelve-month return on equity of 12.06%. Cognyte Software's revenue for the quarter was down 15.0% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.85) earnings per share.

What ETFs hold Cognyte Software's stock?

ETFs with the largest weight of Cognyte Software (NASDAQ:CGNT) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL) and Amplify BlueStar Israel Technology ETF (ITEQ) . Amplify Cybersecurity ETF (HACK) .

What guidance has Cognyte Software issued on next quarter's earnings?

Cognyte Software issued an update on its FY 2025 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of -0.130--0.130 for the period, compared to the consensus estimate of -0.180. The company issued revenue guidance of $333.2 million-$346.8 million, compared to the consensus revenue estimate of $333.5 million.

What other stocks do shareholders of Cognyte Software own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognyte Software investors own include EndoChoice (GI) , Novavax (NVAX) , Sorrento Therapeutics (SRNE) , Exelixis (EXEL) , Fc Global Realty (FCRE) , Galectin Therapeutics (GALT) , Immunomedics (IMMU) , Iovance Biotherapeutics (IOVA) , Neurocrine Biosciences (NBIX) and Nymox Pharmaceutical (NYMX) .

Who are Cognyte Software's major shareholders?

Cognyte Software's stock is owned by a number of institutional and retail investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (0.13%). View institutional ownership trends .

How do I buy shares of Cognyte Software?

Shares of CGNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CGNT

Cognyte Software (CGNT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free CGNT Stock Alerts

$6.42

-0.12 (-1.83%)

(As of 04/19/2024 ET)

Compare

Today's Range: $6.42
▼
$6.59
50-Day Range: $6.42
▼
$8.41
52-Week Range: $4.00
▼
$8.53

Volume: 425,303 shs
Average Volume: 449,447 shs
Market Capitalization: $455.97 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.75

Get Cognyte Software alerts:

Cognyte Software MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 20.7% Upside
$7.75 Price Target
Short Interest: Healthy
0.51% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.83
Upright™ Environmental Score
News Sentiment: 0.92
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.30) to ($0.26) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.72 out of 5 stars

Computer And Technology Sector

204th out of 585 stocks

Prepackaged Software Industry

56th out of 197 stocks

2.0

Analyst's Opinion

Consensus Rating
Cognyte Software has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Cognyte Software has only been the subject of 3 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.51% of the float of Cognyte Software has been sold short.
Short Interest Ratio / Days to Cover
Cognyte Software has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cognyte Software has recently decreased by 24.38%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Cognyte Software does not currently pay a dividend.
Dividend Growth
Cognyte Software does not have a long track record of dividend growth.

3.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Cognyte Software has received a 29.75% net impact score from Upright. Cognyte Software seems to create the most significant positive value in categories "Jobs", "Taxes", and "Knowledge infrastructure". The positive contribution in the "Knowledge infrastructure" impact category is false driven by its "Predictive analytics software" product. See details.
Environmental Sustainability
The Environmental Impact score for Cognyte Software is -0.83.

2.7

News and Social Media Coverage

News Sentiment
Cognyte Software has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Cognyte Software this week, compared to 1 article on an average week.
Search Interest
Only 10 people have searched for CGNT on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days.
MarketBeat Follows
Only 6 people have added Cognyte Software to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cognyte Software insiders have not sold or bought any company stock.
Percentage Held by Insiders
62.70% of the stock of Cognyte Software is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
72.92% of the stock of Cognyte Software is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cognyte Software are expected to grow in the coming year, from ($0.30) to ($0.26) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cognyte Software is -27.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cognyte Software is -27.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cognyte Software has a P/B Ratio of 2.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Cognyte Software Stock (NASDAQ:CGNT)

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. Cognyte Software Ltd. was incorporated in 2020 and is headquartered in Herzliya, Israel.

CGNT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CGNT Stock News Headlines

April 15, 2024 | msn.com

Cognyte Software Stock (NASDAQ:CGNT): Opportunity to Capitalize on Cybercrime Surge

April 13, 2024 | americanbankingnews.com

Wedbush Increases Cognyte Software (NASDAQ:CGNT) Price Target to $8.00

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 11, 2024 | seekingalpha.com

Cognyte Software Ltd. (CGNT) Q4 2024 Earnings Call Transcript

April 11, 2024 | americanbankingnews.com

Cognyte Software (NASDAQ:CGNT) PT Raised to $7.50 at Evercore ISI

April 11, 2024 | americanbankingnews.com

Cognyte Software (NASDAQ:CGNT) Upgraded to "Strong-Buy" at StockNews.com

April 10, 2024 | americanbankingnews.com

Cognyte Software (NASDAQ:CGNT) Given "Hold" Rating at Needham & Company LLC

April 9, 2024 | markets.businessinsider.com

Analysts Conflicted on These Technology Names: Cognyte Software (CGNT) and Harmonic (HLIT)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 9, 2024 | msn.com

Options Volatility and Implied Earnings Moves Today, April 09, 2024

April 9, 2024 | msn.com

CGNT Stock Earnings: Cognyte Software Beats EPS, Beats Revenue for Q4 2024

April 9, 2024 | businesswire.com

Cognyte Reports Fourth Quarter and Fiscal Year Ended January 31, 2024 Financial Results

April 8, 2024 | markets.businessinsider.com

Cognyte Software is about to announce its earnings — here's what Wall Street expects

April 8, 2024 | businesswire.com

Cognyte Appoints Two Veteran Industry Leaders to Board of Directors

March 28, 2024 | businesswire.com

Cognyte to Announce Fourth Quarter and Full Year FY2024 Financial Results on April 9, 2024

March 19, 2024 | marketwatch.com

Best HR Software in 2024

February 5, 2024 | finance.yahoo.com

Cognyte Rings Nasdaq Opening Bell to Celebrate Thirty Years In the Industry, Third Anniversary as Publicly Traded Company

January 23, 2024 | forbes.com

10 Best Project Management Software Of 2024

January 22, 2024 | finance.yahoo.com

Cognyte Announces New Release of LUMINAR Cyber Threat Intelligence Offering with GenAI Capabilities to Bring Added Value to Customers

January 12, 2024 | edition.cnn.com

Best recruiting software in 2024

January 8, 2024 | finance.yahoo.com

Cognyte to Participate in the 26th Annual Needham Growth Conference

December 19, 2023 | finance.yahoo.com

Cognyte Software Ltd. (NASDAQ:CGNT) Q3 2024 Earnings Call Transcript

December 13, 2023 | investorplace.com

CGNT Stock Earnings: Cognyte Software Beats EPS, Beats Revenue for Q3 2024

December 13, 2023 | markets.businessinsider.com

Cognyte Raises FY24 Forecast, Expects $11.5M-$12.5M In Stock-based Compensation Following Strong Q3 Performance

December 13, 2023 | benzinga.com

Cognyte Software: Q3 Earnings Insights

December 13, 2023 | finance.yahoo.com

Cognyte Announces Third Quarter Fiscal 2024 Results

December 11, 2023 | stocknews.com

Cognyte Software (CGNT) Earnings Preview: Software Stock Buy or Sell Signals?

See More Headlines

Receive CGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/15/2023
Today: 4/19/2024
Next Earnings (Estimated): 6/20/2024
Fiscal Year End: 1/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Computer and Technology
Industry: Prepackaged software
Sub-Industry: N/A
Current Symbol: NASDAQ:CGNT
CUSIP: N/A
CIK: 894237
Web: www.cogentixmedical.com
Phone: 972-9962-2300
Fax: N/A
Employees: 1,613
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.75
High Stock Price Target: $8.00
Low Stock Price Target: $7.50
Potential Upside/Downside: +19.2%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-15,570,000.00
Net Margins: -4.97%
Pretax Margin: -4.23%
Return on Equity: -12.06%
Return on Assets: -5.57%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.39
Quick Ratio: 1.26

Sales & Book Value

Annual Sales: $313.40 million
Price / Sales: 1.47
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.12 per share
Price / Book: 2.08

Miscellaneous

Outstanding Shares: 71,020,000
Free Float: 26,492,000
Market Cap: $461.63 million
Optionable: Optionable
Beta: 1.68

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Elad Sharon (Age 48)
CEO & Director
Comp: $1.72M
Mr. David Abadi (Age 50)
Chief Financial Officer
Comp: $1.08M
Mr. Sharon Chouli (Age 54)
Chief Customer Officer
Comp: $780k
Mr. Amir Barel (Age 59)
Chief Technology Officer
Mr. Dean M. Ridlon
Head of Investor Relations
Mr. Ilan Rotem (Age 59)
Chief Legal Officer
Ms. Rini Karlin (Age 52)
Chief People Officer
Mr. Gil Cohen (Age 53)
Chief Product Officer
Mr. Efi Nuri (Age 62)
Chief Revenue Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

CGNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Cognyte Software stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognyte Software in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CGNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNT, but not buy additional shares or sell existing shares.
View CGNT analyst ratings or view top-rated stocks.
What is Cognyte Software's stock price target for 2024?: 3 Wall Street research analysts have issued 1-year target prices for Cognyte Software's stock. Their CGNT share price targets range from $7.50 to $8.00. On average, they expect the company's stock price to reach $7.75 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts price targets for CGNT or view top-rated stocks among Wall Street analysts.
How have CGNT shares performed in 2024?: Cognyte Software's stock was trading at $6.43 on January 1st, 2024. Since then, CGNT stock has decreased by 0.2% and is now trading at $6.42.
View the best growth stocks for 2024 here.
Are investors shorting Cognyte Software?: Cognyte Software saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 329,100 shares, a drop of 24.4% from the March 15th total of 435,200 shares. Based on an average daily volume of 457,300 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.5% of the shares of the company are sold short.
View Cognyte Software's Short Interest.
When is Cognyte Software's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024.
View our CGNT earnings forecast.
How were Cognyte Software's earnings last quarter?: Cognyte Software Ltd. (NASDAQ:CGNT) announced its quarterly earnings data on Thursday, June, 15th. The medical device company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.01. The medical device company had revenue of $73.40 million for the quarter, compared to analyst estimates of $71.53 million. Cognyte Software had a negative net margin of 4.97% and a negative trailing twelve-month return on equity of 12.06%. Cognyte Software's revenue for the quarter was down 15.0% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.85) earnings per share.

What ETFs hold Cognyte Software's stock?: ETFs with the largest weight of Cognyte Software (NASDAQ:CGNT) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL) and Amplify BlueStar Israel Technology ETF (ITEQ).Amplify Cybersecurity ETF (HACK).
What guidance has Cognyte Software issued on next quarter's earnings?: Cognyte Software issued an update on its FY 2025 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of -0.130--0.130 for the period, compared to the consensus estimate of -0.180. The company issued revenue guidance of $333.2 million-$346.8 million, compared to the consensus revenue estimate of $333.5 million.
What other stocks do shareholders of Cognyte Software own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cognyte Software investors own include EndoChoice (GI), Novavax (NVAX), Sorrento Therapeutics (SRNE), Exelixis (EXEL), Fc Global Realty (FCRE), Galectin Therapeutics (GALT), Immunomedics (IMMU), Iovance Biotherapeutics (IOVA), Neurocrine Biosciences (NBIX) and Nymox Pharmaceutical (NYMX).
Who are Cognyte Software's major shareholders?: Cognyte Software's stock is owned by a number of institutional and retail investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (0.13%).
View institutional ownership trends.
How do I buy shares of Cognyte Software?: Shares of CGNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CGNT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cognyte Software (CGNT) Stock Price, News & Analysis

Cognyte Software MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cognyte Software Stock (NASDAQ:CGNT)

CGNT Stock Price History

CGNT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

CGNT Stock Analysis - Frequently Asked Questions

Overall MarketRank^™